Oesophageal Cancer Trial, Recruiting NCT05431738 Sponsor: Société Française d'Endoscopie Digestive Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT05431738
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older of any sex
  • People admitted to one of the participating centres for difficulty swallowing caused by a tumour blocking the area where the stomach meets the oesophagus (food pipe), where the cancer is locally advanced or has spread to other parts of the body
  • People whose overall health status falls within a certain range, assessed as low-to-moderate anaesthetic risk (classified as ASA 1, 2, or 3 — confirm with trial site for details)
  • People who are not currently taking part in another clinical study
  • People who have signed the trial's informed consent form
  • People who are covered by the French social security system

Who may not be able to join:

  • People whose blockage is caused by pressure from a mass outside the digestive system, rather than by a tumour within it
  • People who have a medical reason why the procedure needed to place a stent (a small tube used to open a blocked passage) cannot be safely performed
  • People who have previously had radiotherapy to the chest area or surgery on the oesophagus (food pipe)
  • People under 18 or over 90 years of age
  • People whose overall health is classified as very poor anaesthetic risk (ASA 4 or 5 — confirm with trial site for details)
  • People who are pregnant
  • People who are unable to give their own personal consent to participate
  • People who have not signed the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33603454293

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Société Française d'Endoscopie Digestive
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 September 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Stent Intragastric migration rate at M1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov